## **Core Concept**
The question revolves around the increased risk of malignancies in individuals on immunosuppressive therapy. Immunocompromised patients, including those on immunosuppressive therapy, are at a higher risk of developing certain types of cancer, primarily due to their impaired immune response. This is particularly relevant in the context of post-transplant patients or those with autoimmune diseases.

## **Why the Correct Answer is Right**
The correct answer, **C. Skin**, is related to the fact that skin cancers, including squamous cell carcinoma and basal cell carcinoma, are among the most common malignancies in immunocompromised individuals. The skin's constant exposure to UV radiation makes it particularly susceptible to damage and malignant transformation in the setting of immunosuppression. Immunosuppressive drugs, especially those with high potency like cyclosporine and tacrolimus, have been associated with an increased risk of skin cancers.

## **Why Each Wrong Option is Incorrect**
- **Option A:** While lymphomas, particularly post-transplant lymphoproliferative disorders (PTLD), are a well-recognized complication of immunosuppression, they are not the most common malignancy in these patients.
- **Option B:** Although certain types of viral infections leading to cancers (e.g., HPV-related cervical cancer) can be more prevalent in immunocompromised individuals, the option is too broad and does not specify a particular common malignancy associated with immunosuppression.
- **Option D:** Other malignancies can occur in immunocompromised patients, but they are less commonly associated with immunosuppressive therapy compared to skin cancers.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that **skin cancers are a major concern in patients on long-term immunosuppressive therapy**. Regular dermatological surveillance is recommended for these patients to detect skin cancers early. This is particularly important for patients on long-term immunosuppression post-transplant or for those with autoimmune diseases.

## **Correct Answer:** . Skin